• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. MERIDIAN FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. MERIDIAN FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number MD800F
Device Problems Complete Blockage (1094); Occlusion Within Device (1423); Difficult to Remove (1528); Material Deformation (2976)
Patient Problems Occlusion (1984); No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/29/2015
Event Type  malfunction  
Manufacturer Narrative
No device, no medical records or no medical images have been made available to the manufacturer.As the lot number for the device has not been provided, a review of the device history records could not be performed.The investigation of the reported event is currently underway.
 
Event Description
It was reported that approximately 18 months post vena cava filter deployment, during a scheduled filter retrieval, ivc occlusion was discovered at the level of the filter.No attempts were made to retrieve the filter.No other pertinent medical information was provided surrounding the events.Current patient status is unknown.
 
Manufacturer Narrative
Manufacturing review: a manufacturing review could not be conducted as the lot number was not provided.Visual/microscopic inspection: as the device was not returned, an inspection could not be performed.Functional/performance evaluation: as the device was not returned, an evaluation could not be performed.Medical records review: as medical records were not provided, a review could not be performed.Image/photo review: no medical images have been made available to the manufacturer.Conclusion: the investigation is inconclusive for an occluded ivc at the level of the filter.Based upon the available information, the definitive root cause for this event is unknown.Labeling review: the current ifu (instructions for use) states: warnings: note: it is possible that complications such as those described in the "warnings", "precautions," or "potential complications" sections of this instructions for use may affect the recoverability of the device and result in the clinician's decision to have the device remain permanently implanted.Potential complications: caval thrombosis/occlusion the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Manufacturer Narrative
Medical records review: the patient had a prophylactic inferior vena cava filter placed for prolonged immobility and intracranial hemorrhage.The right groin was prepped and draped in usual sterile fashion.The right common femoral vein was accessed and the filter was successfully deployed in an infrarenal location.The patient tolerated the procedure well without immediate complication.Conclusion: the device was not returned.Images were not received.Medical records were provided.The medical records allege a vena cava filter was implanted successfully in an infrarenal location via the right common femoral vein.No deficiencies were reported within the medical records.The investigation is inconclusive for the reported event.Based upon the available information, the definitive root cause for this event is unknown.(b)(4).The information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.
 
Event Description
New information received - it was reported by the patient a vena cava filter was deployed in conjunction with a trauma situation/motor vehicle accident.After an unknown amount of time post filter deployment, an unsuccessful percutaneous filter retrieval attempt was performed.Based on medical records received from the patient, it was identified a vena cava filter was deployed successfully for dvt prophylaxis.The patient tolerated the procedure well.No additional information was received in the medical records provided.
 
Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.The medical records included images.The image review was documented in the medical records.Medical records were provided and reviewed.Approximately one year and six months later, first attempt was made to retrieve the inferior vena cava filter from the patient¿s body.Through the ultrasound-guided right internal jugular vein access, a 0.035 inch j wire was advanced through the micropuncture sheath into the inferior vena cava.A spot magnification view of the bard meridian filter demonstrated the filter was intact and at the level of l2-l3.There was no significant tilt.The arms and legs were contracted compared to prior images.The guidewire was then attempted to be advanced into the inferior vena cava below the level of the filter; however, resistance was encountered at the level of the filter.The j wire was exchanged for a 0.035 inch stiff glidewire, and again attempts were made to advance beyond the level of the filter; these were unsuccessful.A 5 french kumpe catheter was advanced over the wire and attempts were made; however, it was not possible to traverse beyond the level of the filter secondary to occlusion of the inferior vena cava at this level.An injected contrast demonstrated chronic occlusion of the inferior vena cava at the level of the filter.As the patient had no complaints in regard to this filter, the procedure was terminated.Hemostasis was obtained using manual compression.After four years and six months, a computed tomography (ct) abdomen and pelvis with intravenous contrast showed that there was an inferior vena cava filter in place.The cava inferior to the level of this filter was occluded.On the next day, second attempt was made to retrieve the chronic total occluded inferior vena cava filter from the patient¿s body.Through the ultrasound-guided right internal jugular vein access, a sheath was up sized to 11-french sheath.Using a 15 mm loop snare, the physicians were able to snare the hook of the inferior vena cava filter; however, there was significant adherence of the inferior vena cava filter to the surrounding scar tissue, as a result of which the physicians were unable to retrieve the filter in this fashion.At this point, the 16 french 45 cm sheath was switched out to 16 french 50 cm laser sheath and this was done without losing snare capture of the inferior vena cava filter.Using gentle taps, the physicians were able to completely break down the scar tissue around the inferior vena cava filter and completely retrieved the inferior vena cava filter into the sheath.The laser sheath with the inferior vena cava filter was completely removed and the filter was sent to pathology.A cavogram demonstrated a patent vena cava without any evidence of extravasation.Hemostasis was achieved and a compressive dressing was applied.On the same day, the surgical pathology report¿s gross description mentioned that ¿the specimen designated as inferior vena cava (ivc) filter was received in fresh in a container labeled with the patient¿s name and medical record number and consisted of a bundle of wires that measured 4 cm in length entailed by a clamp on one end that measured 0.4 cm.The very end had a little filter on it which measured 2 cm in length.The specimen was placed aside for patient pick-up¿.Therefore, the investigation is confirmed for the alleged filter occlusion, material deformation and retrieval difficulties.Based upon the available information, the definitive root cause for this event is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with trauma situation/motor vehicle accident.Approximately eighteen months post vena cava filter deployment, during a scheduled filter retrieval, inferior vena cava occlusion was discovered at the level of the filter.The device has not been removed after an attempted but unsuccessful percutaneous removal procedure.The current status of the patient is unknown.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with trauma situation/motor vehicle accident.Approximately eighteen months post vena cava filter deployment, during a scheduled filter retrieval, inferior vena cava occlusion was discovered at the level of the filter.The device has not been removed after an attempted but unsuccessful percutaneous removal procedure.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: as the lot number for the device was provided, a review of the device history records is currently being performed.The device has not been returned to the manufacturer for evaluation.The investigation of the reported event is currently underway.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MERIDIAN FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key5478498
MDR Text Key39854544
Report Number2020394-2016-00237
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K112497
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 11/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/03/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberMD800F
Device Lot NumberGFXF3382
Was Device Available for Evaluation? No
Date Manufacturer Received11/24/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/26/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age55 YR
Patient SexMale
Patient Weight121 KG
Patient EthnicityNon Hispanic
-
-